Jump to content

Semustine: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
No edit summary
AnomieBOT (talk | contribs)
m Dating maintenance tags: {{Fact}} {{Globalize}}
Line 1: Line 1:
{{globalize}}
{{globalize|date=May 2012}}
{{Drugbox
{{Drugbox
| Watchedfields = changed
| Watchedfields = changed
Line 43: Line 43:


'''Semustine''' is a drug used in [[chemotherapy]].<ref>{{pmid|1548520}}</ref>
'''Semustine''' is a drug used in [[chemotherapy]].<ref>{{pmid|1548520}}</ref>
It is structurally similar to [[lomustine]], being distinguished from it only by an additional [[methyl]] group. It has been taken off the drug market for investigation of its cancerous effects, rated as [[IARC Group 1 carcinogen]] or a known carcinogen.{{fact}}
It is structurally similar to [[lomustine]], being distinguished from it only by an additional [[methyl]] group. It has been taken off the drug market for investigation of its cancerous effects, rated as [[IARC Group 1 carcinogen]] or a known carcinogen.{{fact|date=May 2012}}


==References==
==References==

Revision as of 17:34, 30 May 2012

Semustine
Clinical data
ATC code
Identifiers
  • N-(2-Chloroethyl)-N'-(4-methylcyclohexyl)-N-nitrosourea
CAS Number
PubChem CID
UNII
KEGG
CompTox Dashboard (EPA)
ECHA InfoCard100.162.271 Edit this at Wikidata
Chemical and physical data
FormulaC10H18ClN3O2
Molar mass247.72 g/mol g·mol−1
  (verify)

Semustine is a drug used in chemotherapy.[1] It is structurally similar to lomustine, being distinguished from it only by an additional methyl group. It has been taken off the drug market for investigation of its cancerous effects, rated as IARC Group 1 carcinogen or a known carcinogen.[citation needed]

References

  1. ^ PMID 1548520